Carbestrol

Carbestrol
Systematic (IUPAC) name
3-Ethyl-4-(4-methoxyphenyl)-2-methylcyclohex-3-ene-1-carboxylic acid
Identifiers
CAS Number 1755-52-8
ATC code None
PubChem CID 15644
ChemSpider 14881
Chemical data
Formula C17H22O3
Molar mass 274.35478 g/mol

Carbestrol (developmental code names NSC-19962, ORF-2166) is a synthetic, non-steroidal estrogen of the cyclohexenecarboxylic acid group and seco analogue of doisynolic acid that was developed for the treatment of prostate cancer in the 1960s but was never marketed.[1][2][3][4]

See also

References

  1. J. Elks (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 516–. ISBN 978-1-4757-2085-3.
  2. ARDUINO LJ (1964). "CARBESTROL (NSC-19962) TREATMENT OF PATIENTS WITH PROSTATIC CARCINOMA-PRELIMINARY REPORT". Cancer Chemother Rep 39: 67–75. PMID 14201278.
  3. Kogler J, Hill G, Sedransk N, Cole DR, Weiss AJ, Wilson W (1972). "Phase II study of carbestrol (NSC-19962) in patients with solid tumors". Cancer Chemother Rep 56 (5): 641–7. PMID 4652590.
  4. Raymond Eller Kirk; Donald Frederick Othmer (1980). Encyclopedia of chemical technology. Wiley. p. 672. ISBN 978-0-471-02065-3.



This article is issued from Wikipedia - version of the Tuesday, April 05, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.